2022 annual financial data
Celldex Therapeutics 2022 Operating margin
Direct answer
Operating margin was -4,889.01%.
Operating income was -115,234,000 USD and net income was -112,325,000 USD.
Operating cash flow was -103,732,000 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,357,000 USD
- Operating income
- -115,234,000 USD
- Net income
- -112,325,000 USD
- Operating cash flow
- -103,732,000 USD